EE02950B1 - Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon - Google Patents
Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioonInfo
- Publication number
- EE02950B1 EE02950B1 EE9400299A EE9400299A EE02950B1 EE 02950 B1 EE02950 B1 EE 02950B1 EE 9400299 A EE9400299 A EE 9400299A EE 9400299 A EE9400299 A EE 9400299A EE 02950 B1 EE02950 B1 EE 02950B1
- Authority
- EE
- Estonia
- Prior art keywords
- pct
- groups
- group
- independently
- formula
- Prior art date
Links
- MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical compound OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- -1 methylenebisphosphonic acid ester amide Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/44—Amides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/44—Amides thereof
- C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4423—Amides of poly (thio)phosphonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Paints Or Removers (AREA)
- Detergent Compositions (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Luminescent Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI906296A FI89365C (fi) | 1990-12-20 | 1990-12-20 | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat |
Publications (1)
Publication Number | Publication Date |
---|---|
EE02950B1 true EE02950B1 (et) | 1996-12-16 |
Family
ID=8531621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9400299A EE02950B1 (et) | 1990-12-20 | 1994-11-14 | Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon |
Country Status (25)
Country | Link |
---|---|
US (1) | US5442101A (et) |
EP (1) | EP0570380B1 (et) |
JP (1) | JPH06504770A (et) |
KR (1) | KR930703336A (et) |
CN (1) | CN1028866C (et) |
AT (1) | ATE171182T1 (et) |
AU (1) | AU663268B2 (et) |
CA (1) | CA2098734A1 (et) |
CZ (1) | CZ119593A3 (et) |
DE (1) | DE69130231T2 (et) |
DK (1) | DK0570380T3 (et) |
EE (1) | EE02950B1 (et) |
ES (1) | ES2121003T3 (et) |
FI (1) | FI89365C (et) |
HU (1) | HUT64547A (et) |
IE (1) | IE914390A1 (et) |
IL (1) | IL100336A (et) |
NO (1) | NO303121B1 (et) |
NZ (1) | NZ241039A (et) |
PL (1) | PL169728B1 (et) |
RU (1) | RU2100364C1 (et) |
SK (1) | SK63093A3 (et) |
TW (1) | TW203053B (et) |
WO (1) | WO1992011268A1 (et) |
ZA (1) | ZA9110007B (et) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1469003A3 (en) * | 1996-10-09 | 2004-11-24 | Pharmasset, Ltd. | Tetraphosphonate bicyclic trisanhydrides |
ATE271058T1 (de) | 1996-10-09 | 2004-07-15 | Pharmasset Ltd | Mycophenol bisphosponatverbindungen |
US20040181078A1 (en) * | 1997-10-10 | 2004-09-16 | Pharmasset, Ltd. | Tetraphosphonate bicyclic trisanhydrides |
FI104901B (fi) * | 1997-10-20 | 2000-04-28 | Leiras Oy | Uudet metyleenibisfosfonihappojohdannaiset |
US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
WO2005090370A1 (en) | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
US20070003608A1 (en) * | 2005-04-08 | 2007-01-04 | Almond Merrick R | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
EP1868628B1 (en) | 2005-04-08 | 2014-06-11 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
WO2009094190A2 (en) * | 2008-01-25 | 2009-07-30 | Chimerix, Inc. | Methods of treating viral infections |
US8614200B2 (en) | 2009-07-21 | 2013-12-24 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
WO2011017253A1 (en) | 2009-08-03 | 2011-02-10 | Chimerix, Inc. | Composition and methods of treating viral infections and viral induced tumors |
HUE032860T2 (en) | 2010-02-12 | 2017-11-28 | Chimerix Inc | A method for treating a virus infection |
CN102190684A (zh) * | 2010-03-15 | 2011-09-21 | 南通波锐生物医药有限公司 | 一种具有药物应用的含磷化合物及其制备和用途 |
WO2011139709A2 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
CN102453050B (zh) * | 2010-11-03 | 2015-01-07 | 成都云克药业有限责任公司 | 一种二膦酸化合物及其制备方法 |
WO2018005659A1 (en) * | 2016-06-28 | 2018-01-04 | Aequor, Inc. | Antimicrobial compounds and methods of use |
RU2630226C1 (ru) * | 2016-12-20 | 2017-09-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный университет" | Новая ионная жидкость производная бис-(N,N-диметиламида) метилфосфоновой кислоты с высокими термическими свойствами |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4293505A (en) * | 1967-04-06 | 1981-10-06 | Randall David I | Preparation of β-haloethylphosphonic acids and half esters thereof |
US3524846A (en) * | 1967-06-02 | 1970-08-18 | Syntex Corp | Process for the didealkylation of phosphonate esters |
US3808265A (en) * | 1971-03-26 | 1974-04-30 | Gaf Corp | Preparation of 2-haloethylphosphonic acid |
IT1187828B (it) * | 1985-05-24 | 1987-12-23 | Gentili Ist Spa | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi |
US5212164A (en) * | 1988-08-29 | 1993-05-18 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors |
US5273969A (en) * | 1988-08-29 | 1993-12-28 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors and method |
EP0356866A3 (en) * | 1988-08-29 | 1991-03-27 | E.R. SQUIBB & SONS, INC. | Phosphorus-containing squalene synthetase inhibitors and method |
FI89366C (fi) * | 1990-12-20 | 1993-09-27 | Leiras Oy | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat |
-
1990
- 1990-12-20 FI FI906296A patent/FI89365C/fi not_active IP Right Cessation
-
1991
- 1991-12-11 IL IL10033691A patent/IL100336A/en not_active IP Right Cessation
- 1991-12-17 IE IE439091A patent/IE914390A1/en not_active Application Discontinuation
- 1991-12-18 HU HU9301780A patent/HUT64547A/hu unknown
- 1991-12-18 CA CA002098734A patent/CA2098734A1/en not_active Abandoned
- 1991-12-18 CZ CS931195A patent/CZ119593A3/cs unknown
- 1991-12-18 RU RU9393050805A patent/RU2100364C1/ru active
- 1991-12-18 WO PCT/FI1991/000396 patent/WO1992011268A1/en not_active Application Discontinuation
- 1991-12-18 DE DE69130231T patent/DE69130231T2/de not_active Expired - Fee Related
- 1991-12-18 AU AU90800/91A patent/AU663268B2/en not_active Ceased
- 1991-12-18 US US08/078,155 patent/US5442101A/en not_active Expired - Fee Related
- 1991-12-18 AT AT92901217T patent/ATE171182T1/de not_active IP Right Cessation
- 1991-12-18 JP JP4502098A patent/JPH06504770A/ja active Pending
- 1991-12-18 SK SK630-93A patent/SK63093A3/sk unknown
- 1991-12-18 NZ NZ241039A patent/NZ241039A/en unknown
- 1991-12-18 DK DK92901217T patent/DK0570380T3/da active
- 1991-12-18 KR KR1019930701879A patent/KR930703336A/ko active IP Right Grant
- 1991-12-18 PL PL91299980A patent/PL169728B1/pl unknown
- 1991-12-18 EP EP92901217A patent/EP0570380B1/en not_active Expired - Lifetime
- 1991-12-18 ES ES92901217T patent/ES2121003T3/es not_active Expired - Lifetime
- 1991-12-19 ZA ZA9110007A patent/ZA9110007B/xx unknown
- 1991-12-20 CN CN91111881A patent/CN1028866C/zh not_active Expired - Fee Related
- 1991-12-31 TW TW081100320A patent/TW203053B/zh active
-
1993
- 1993-06-18 NO NO932256A patent/NO303121B1/no unknown
-
1994
- 1994-11-14 EE EE9400299A patent/EE02950B1/et unknown
Also Published As
Publication number | Publication date |
---|---|
FI89365C (fi) | 1993-09-27 |
KR930703336A (ko) | 1993-11-29 |
CA2098734A1 (en) | 1992-06-21 |
TW203053B (et) | 1993-04-01 |
CN1028866C (zh) | 1995-06-14 |
ZA9110007B (en) | 1992-09-30 |
IL100336A (en) | 1998-07-15 |
NZ241039A (en) | 1993-05-26 |
CZ119593A3 (en) | 1994-02-16 |
DE69130231D1 (de) | 1998-10-22 |
IL100336A0 (en) | 1992-09-06 |
DK0570380T3 (da) | 1999-02-08 |
JPH06504770A (ja) | 1994-06-02 |
CN1062533A (zh) | 1992-07-08 |
NO932256L (no) | 1993-08-20 |
SK63093A3 (en) | 1993-12-08 |
ES2121003T3 (es) | 1998-11-16 |
ATE171182T1 (de) | 1998-10-15 |
RU2100364C1 (ru) | 1997-12-27 |
US5442101A (en) | 1995-08-15 |
WO1992011268A1 (en) | 1992-07-09 |
FI906296A (fi) | 1992-06-21 |
NO932256D0 (no) | 1993-06-18 |
EP0570380A1 (en) | 1993-11-24 |
HUT64547A (en) | 1994-01-28 |
AU663268B2 (en) | 1995-09-28 |
PL169728B1 (pl) | 1996-08-30 |
AU9080091A (en) | 1992-07-22 |
FI89365B (fi) | 1993-06-15 |
HU9301780D0 (en) | 1993-09-28 |
EP0570380B1 (en) | 1998-09-16 |
FI906296A0 (fi) | 1990-12-20 |
IE914390A1 (en) | 1992-07-01 |
DE69130231T2 (de) | 1999-03-25 |
NO303121B1 (no) | 1998-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE02950B1 (et) | Metüleenbisfosfoonhappe esteramiidderivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon | |
DK0618920T3 (da) | Hidtil ukendte phosphonravsyrederivater, fremgangsmåde til fremstilling heraf samt lægemidler indeholdende disse forbindelser | |
HUT46024A (en) | Process for producing diphosphonic acid derivatives and pharmaceutical compositions containing them as active components | |
DK151627C (da) | Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf. | |
DE3869173D1 (de) | Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
ATE150301T1 (de) | Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen | |
ATE128139T1 (de) | Neue methylenbisphosphonsäurederivate. | |
DE69909782D1 (de) | Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris | |
DK0823909T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
NZ219758A (en) | Heterocyclic ester derivatives of 1,4 dihydropyridin-3,5-dicarboxylic acids intermediates and pharmaceutical compositions | |
ES2057116T3 (es) | Derivados de acido n-(5,6,7,8-tetrahidropirido-(2,3-d)pirimidin-6-ilalcanoil) glutamico. | |
DK0451626T3 (da) | Anvendelse af benzodiazepinforbindelser til fremstilling af et farmaceutisk præparat mod med excitatoriske aminosyrer forbundne forstyrrelser i centralnervesystemet | |
ES2027492A6 (es) | Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables. | |
ES2150149T3 (es) | Derivados de 17-beta-(2-oxo-tetrahidrofuran-4-il)-tio-androstano (tioderivados de 17-beta-(lactona del acido gamma-butirico)) para el tratamiento de la inflamacion, composiciones farmaceuticas y un procedimiento para la produccion de los mismos. | |
ES8403123A1 (es) | "procedimiento para la preparacion de esteres del acido alcoxivincaminico". | |
ES2005778A6 (es) | Procedimiento para la obtencion de derivados de diisobutilxantina. |